Regan Zambri Long PLLC
English Español
Call Now 202-960-4596
Menu
04/27/09   |   By

FDA Recall of Dietary Supplement Products Containing Undeclared Drug Sibutramine | DC Metro Area Personal Injury Law Blog

5 stars

According to a recent report, Food and Drug Administration lab analyses identified undeclared sibutramine in 34 dietary supplement products distributed by Universal ABC Beauty Supply.

Product packaging on these dietary supplements were not labeled as containing the drug. Sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss, has not been approved for use in dietary supplements and has been found to substantially increase blood pressure and pulse rate in some consumers. Patients are advised to consult with health care professionals before use of the drug. Sibutramine also presents risks for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

For a full list of the recalled dietary supplements visit the April 20, 2009 press release. Health care professionals and consumers may report adverse reactions to the use of these products to the FDA’s Medwatch Adverse Event Reporting program. Further information about this program can be obtained on the FDA’s website.

For information about defective medications and your rights, please click here or contact Regan Zambri & Long, PLLC at (202) 463-3030.

Regan Zambri Long
Posted In
Uncategorized
Share This Article

Archives

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Back to Top